Determinants of health and health care expenditures (ścieżka III)

1. A student has detailed knowledge about the financing of health care system in selected countries, knows the main factors influenced the level of sector revenues and expenditures.

2. A student has a knowledge about principles of construction and writing of reports and scientific papers

Abilities:

3. A student can search, evaluate, analyze and join information from different sources and project a potential financial risk on this base

4. A student can present results of research in a form of presentation and paper

5. A student knows foreign language, understands the meaning of the main idea of complex texts, connected with a public health as well

Social competences:

6. A student can formulate clear and detailed oral and written statements, explain his/her position on matters of discussion

7. A student can independently acquire knowledge and broaden their research skills using objective sources of information

- project preparation: 15 hours - 0,5 ECTS

- analysis of results and their presentation in the oral and written form: 15 hours - 0,5 ECTS

- Discussions

- Projects prepared by students (prognostic model in Excel)

course grading

Effect 2 - paper prepared by a student

Effect 5, 6 - presentation and paper, participation in discussions

- the accuracy and completeness of forecasts (0-5 points),

-the structure of the report (0-5 points)

To receive positive assessment, each part has to be rated at least 3 points.

9.5-10 points: 5.0 (very good);

8.5-9 points: 4.5 (good plus);

7.5-8 points: 4.0 (good);

6.5-7 points: 3.5 (sufficient plus);

6 points: 3.0 (sufficient)

below 6 points: 2.0 (insufficient)

- Sources of revenues of health care system in selected countries and factors influenced the level of revenues,

- Projections of health expenditures and revenues: basic models, especially actuarial type.

• 
  Golinowska S., Kocot E., Sowa A. (2007), Health Expenditure Scenarios in the New Member States. Comparative Report on Bulgaria, Estonia, Hungary, Poland and Slovakia, ENEPRI Research Reports No.43
  
• 
  Cichon M. et.al. (1999), Modelling in health care finance, International Labour Office, Geneva (selected parts)
  
• 
  OECD (2013), Public spending on health and long-term care: a new set of projections, OECD Economic Policy Papers No.06
  
• 
  Przywara B. (2010), Projecting future health care expenditure at European level: drivers, methodology and main results, European Economy, Economic Papers 417
  

1. Student has deepened knowledge on organization and financing of provision of pharmaceuticals within health care systems in Poland and worldwide, as well as basic knowledge on organization and financing of provision of medical devices.

2. Student has deepened knowledge on legal regulations pertaining to local, national and international health policy and social policy in area of pharmaceuticals (medicinal products). Student has also knowledge on the above mentioned legal regulations in area of medical devices.

3. Student critically assesses main trends and projects in area of pharmaceutical policy, in local and national context and from broader, European and global perspective.

4. Student has ability to independently formulate and propose solutions of concrete problems related to economics and management of pharmaceuticals and medical devices. Student has also skills necessary for implementing procedures related to undertaking relevant solutions.

5. Student can perform critical analysis and interpretation of scientific publications, expert reports and analyses from area of public health focusing on provision of pharmaceuticals.

6. Student knows foreign language - understands meaning of main plots of content of complex texts on concrete and abstract topics. This includes understanding of relevant issues of pharmacoeconomics, pharmaceutical policy, pharmaceutical pricing and reimbursement policy and provision of pharmaceuticals and medical devices.

7. Student shows engagamement in promotion of rational managament of pharmaceuticals and shows interest in problems of pharmaceutical policy (understood as important element of health policy).

8. Student can formulate, in a broad extent, clear and detailed statements, both in written and orally. Student can also explain his/her position on issues at stake, analyzing advantages and disadvantages of various solutions in area of provision of pharmaceuticals and medical devices.

9. Student can independently gather knowledge and expand research skills, utilizing objective sources of information. Student can also undertake autonomous actions aiming to solve practical problems in area of provision of pharmaceuticals and medical devices.

prof. dr hab. med. Andrzej Pilc

dr n. med. Paweł Kawalec

English language skills at level enabling to efficiently utilize scientific literature and actively participate in seminars.

- preparation for seminars: 25 hours - 1 ECTS

- realization of project and presentation of its results: 25 hours - 1 ECTS

- preparation for exam and participation in it: 30 hours - 1 ECTS

Discussion on issues related to didactic content, including student's knowledge, experience and observations.

Individual or group project, followed by presentation on forum of group of students and discussion.

Implementation of "e-learning" techniques, tailored to needs and possibilities of particular groups of students, is possible.

course grading

Assessment criteria and course grading:

Grade 2 – Student has not sufficient knowledge on organization and financing of provision of pharmaceuticals, on relevant legal regulations and international aspects of drug management and economics. Student has not sufficient abilities to independently work on problems related to drug economics, to critically interpret relevant literature and to understand discussion on drug economics issues in foreign language. Student has not sufficient social competencies related to drug economics research and utilization.

Grade 3 – Student has limited knowledge on organization and financing of provision of pharmaceuticals, on relevant legal regulations and international aspects of drug management and economics. Student has limited abilities to independently work on problems related to drug economics, to critically interpret relevant literature and to understand discussion on drug economics issues in foreign language. Student has limited social competencies related to drug economics research and utilization.

Grade 4 – Student has sufficient knowledge on organization and financing of provision of pharmaceuticals, on relevant legal regulations and international aspects of drug management and economics. Student has sufficient abilities to independently work on problems related to drug economics, to critically interpret relevant literature and to understand discussion on drug economics issues in foreign language. Student has sufficient social competencies related to drug economics research and utilization.

Grade 5 - Student has fluent knowledge on organization and financing of provision of pharmaceuticals, on relevant legal regulations and international aspects of drug management and economics. Student has outstanding abilities to independently work on problems related to drug economics, to critically interpret relevant literature and to understand discussion on drug economics issues in foreign language. Student has outstanding social competencies related to drug economics research and utilization.

Pharmaceuticals and medical devices, their role in medicine and health care system.

Basic concepts on pharmacology and pharmacological treatment.

General characteristics of pharmaceutical market.

National drug policies and their stakeholders.

Pricing and reimbursement of pharmaceuticals and relevant aspects of pharmaceutical policy.

Drug utilization analyses.

Hospital pharmacies and their role in rational drug management in hospitals.

Risk of fraud and corruption on pharmaceutical market and strategies aimed to prevent and overcome them.

Pharmacoeconomic analyses.

Application of health technology assessment (HTA) and evidence-based medicine (EBM) in areas of pharmacological therapy and use of medical devices.

Practical exercises in pharmacoeconomics and drug management.

• 
  Quick J.D. et al. (1997), Managing drug supply, Management Sciences for Health, Kumarian Press, New York (selected chapters)
  
• 
  Schweitzer S.O. (2007), Pharmaceutical economics and policy, Oxford University Press, Oxford (selected chapters)
  
• 
  Strom B.L. (1989), Pharmacoepidemiology, Churchill Livingstone, New York, Edinburgh, London, Melbourne(selected chapters)
  
• 
  Sloan F.A., Hsieh C.R. (2007), Pharmaceutical innovation. Incentives, competition, and cost-benefit analysis in international perspective, Cambridge University Press, Cambridge (selected chapters)
  
• 
  European Observatory on Health, Systems and Policies (2011), Health Systems in Transition, Poland Health System Review, WHO Copenhagen
  
• 
  WHO (2010) Continuity and Change. Implementing the third WHO Medicines Strategy 2008-2013, WHO
  
• 
  Dukes MNG et al. (2004), Drugs and money. Prices, affordability and cost containment, IOS Press, Amsterdam
  
• 
  WHO (2001), How to develop and implement a national drug policy, WHO, Geneva
  
• 
  Espin J., Rovira J. (2007), Analysis of differences and commonalities in pricing and reimbursement systems in Europe, EASP, Granada
  
• 
  Mossialos E. et al. (2004), Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality, Open University Press, Berkshire
  

Supplementary literature:

• 
  Other scientific sources, including papers from specialist scientific literature, are recommended or delivered to students before some seminars, depending on individual research topic and project of a student.
  

1. Student obtains knowledge on models of health care funding, types of social health insurance and national health system, types of private health insurance, out -of -pocket payments.

2. Fiscal balance in health care system.

3. Providers payment methods.

4. To assess health care system funding based on defined criteria. To understand cultural influence and past dependency of health care systems.

5. To analyse and present health care system in a given country

6. To find and select an adequate literature and data.

7. Team working and cooperation within multicultural groups. Openness to different approaches and solution related to health issues.

8. Sensitivity and responsibility for efficiency and sustainable health care funding.

9. Understanding and use of ethical principles in health care.

mgr Marzena Tambor

mgr Irmina Jurkiewicz-Świętek

- self-education: 25 hours - 1 ECTS

- preparation for final examination: 30 hours - 1 ECTS

- preparation of essays and presentation: 25 hours - 1 ECTS

course grading

2. -written examination, essays evaluation

3. -written examination, essays evaluation

4. - evaluation of individual work (essay, oral presentation)

5. - evaluation of individual work (essay, oral presentation)

6. -evaluation of individual work (essay, oral presentation)

7. - evaluation of team work, group discussions

8. - evaluation of team work, group discussions

9. - evaluation of team work, group discussions

Grade 2:

Grade 3: The essay and the presentation prove student’s ability to gather basic data on health care system of a given country, basic knowledge how the system functions and ability to present in the written form and in the oral form.

Grade 4:

The essay and the presentation prove student’s ability to gather relevant data on health care system in a given country, good knowledge and understanding how the system functions and good writing and presenting skills.

Grade 5:

The essay and the presentation prove student’s ability to gather broad range of relevant data on health care system in a given country, deep knowledge and very good understanding how the system functions and ability to analyze and evaluate the health care system. Student’s writing skills and presentation skills are very good.

2. Social health insurance and national health system

3. Private health insurance

4. Out -of -pocket payments

5. Providers payment methods

• 
  Culyer A., Newhouse J. (ed.) (2005), Handbook of Health Economic's volume 1A, fourth impression, Elsevier North Holland, Amsterdam a.o.
  
• 
  Wonderling D., Gruen R., Black N. (2005), Introduction to health Economics, Open University Press, Maidenhead
  
• 
  Mossialos E., Thomson S. (2002), Voluntary health insurance in the EU, Report prepaerd for the Directorate General for Employment and Social Affairs of the Europen Commission
  
• 
  Phelp S. (1992), Health Economics, HarperCollinsPublishers, New York
  
• 
  Zweifel P., Breier F. (1997), Health Economics, Oxford University Press
  
• 
  Folland S., Goodman A., Stano M. (2003), Economics of Health and Health Care, fourth (or fifth) edition, Pearson Prentice Hall, Upper Saddle River NJ
  
• 
  Mossialos M., Dixon A., Figueras F., Kutzin J., (2002), Funding health care: options for Europe, Open University Press, European Observatory on Health Systems and Polices, WHO, Buckingham - Philadelphia
  
• 
  Morris S., Devlin N., Parkin D. (2007), Economic Analysis in Health Care, John Wiley and Sons, Chichester